health_en

Insightec Announces Registration Approval Of Exablate Neuro By Singapore Health Sciences Authority

Positive momentum continues to bring Focused Ultrasound to global patients living with Essential Tremor and Tremor-dominant Parkinson’s Disease Insightec®, a global healthcare company focused on creating the next generation of patient care, announced approval of the Exablate® Neuro platform by the Health Sciences Authority (HSA) in Singapore. The Exablate Neuro (Exablate 4000) platform uses Focused […]

thaipr.net

5 ก.ค. 64

Ramesh Subrahmanian joins Everlife Board

Everlife Holdings Pte. Ltd. (“Everlife”), a leading manufacturer and distributor of medical devices and laboratory equipment and consumables in Asia, has appointed Ramesh Subrahmanian to the company’s Board of Directors. Ramesh is a seasoned leader in the healthcare industry with over 25 years of global senior management experience in the pharmaceuticals, vaccines, and medical devices […]

thaipr.net

5 ก.ค. 64

New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro (GL-LIS), and Glargine (GL-GLA) Presented at the American Diabetes Association’s 81st Scientific Sessions

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), announced positive Phase 1 clinical trial results at the 81st Scientific Sessions of the American Diabetes Association (ADA), June 25th – 29th. The new data pertained to three proposed biosimilar Gan & Lee insulin analogs, insulin aspart (GL-ASP), insulin lispro […]

thaipr.net

2 ก.ค. 64

Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusive Asia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. OSSIS, a New Zealand based company, specializes in complex hip replacements including second-time hip replacement, and replacement involving […]

thaipr.net

1 ก.ค. 64

RedHill Biopharma’s Opaganib Inhibits COVID-19 Variants in Preclinical Study

Opaganib strongly inhibits Beta (South African) and Gamma (Brazilian) COVID-19 variants, further supporting its antiviral activity    Opaganib’s unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain effect against other emerging variants, including the Delta (Indian) variant Completion of opaganib’s global fully enrolled 475-patient Phase 2/3…

thaipr.net

29 มิ.ย. 64
1 … 106 107 108 109 110 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.